Central Auditory Processing Disorders Associated With Blast Exposure
Study Details
Study Description
Brief Summary
The incidence of central auditory dysfunction in war fighters who are exposed to high-explosive blasts while serving in combat have not been clearly determined. The objectives of this study are to determine whether central auditory processing (CAP) disorders are associated with exposure to high-explosive blasts. This study will also examine the incidence, magnitude and timing of spontaneous recovery of CAP function from blast exposure. The information provided by this study will help guide clinicians in both the military and VA health care systems regarding the likelihood of central auditory processing disorders in soldiers returning from deployment and suggest some clinical rehabilitative strategies for the treatment of these patients with CAP deficits.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The incidence and nature of central auditory dysfunction in combat soldiers who are exposed to high-explosive blasts have not been determined. Using a battery of behavioral and neurophysiological auditory tests, we propose to evaluate central auditory function in soldiers who recently have been exposed to explosive blasts while deployed in Iraq or Afghanistan. In collaboration with the Army Audiology & Speech Center at Walter Reed Army Medical Center (WRAMC), the research will be coordinated at the National Center for Rehabilitative Auditory Research (NCRAR) at the Portland VA Medical Center, and data collection will take place both at the NCRAR and at WRAMC. The study objectives are to determine if specific central auditory processing disorders are often associated with exposure to high-explosive blasts, and if these disorders spontaneously recover or remain over time. One hundred patients who have suffered a blast exposure, but have either no brain damage or mild traumatic brain injury (TBI), will be recruited at WRAMC to participate in this research study. A battery of central auditory processing tests will be administered to participants as soon as possible after their arrival at WRAMC. Patients who demonstrate aspects of central auditory processing disorder will be invited to participate in further testing nine to twelve months later. Those subjects will be brought to the NCRAR at the Portland VA Medical Center or will return to WRAMC for two days of auditory testing, where they will undergo the same battery of tests administered initially. Control subjects who do not have a history of blast exposure and who are matched in age, gender, and audiometric configuration with the experimental subjects will also be tested at the NCRAR site. Data extracted by interview and from medical records, including details of the blast exposure, scores on overall tests of brain function administered by the WRAMC TBI team, presence or absence of post traumatic stress disorder, as well as self-report questionnaires regarding quality of life, presence of tinnitus and/or balance problems, will be used in the interpretation of results.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Blast The study group includes soldiers who have recently been exposed to a high-explosive blast while stationed in Iraq or Afghanistan. They will be recruited at Walter Reed Army Medical Center, Washington, DC. They will undergo audiological testing. |
Procedure: Audiological testing
Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system.
|
Active Comparator: Control Control group are subjects matched to the experimental group by age, gender, and hearing loss, but who have not been exposed to a blast. They will undergo the same audiological testing as the experimental group |
Procedure: Audiological testing
Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system.
|
Outcome Measures
Primary Outcome Measures
- Audiological Test Results [three years]
Audiometric testing, with normal hearing specified as better (lower) than 25 decibels Hearing Level (dBHL), and a mild hearing loss between 25 to 50 dBHL.
Secondary Outcome Measures
- Quality of Life Questionnaire [Three years]
Self-report questionnaires regarding quality of life
Eligibility Criteria
Criteria
Inclusion Criteria:
Experimental group:
-
Active duty soldier at Walter Reed Army Medical Center, Washington DC
-
a notation in medical record of exposure to blast
-
a Glasgow Coma Scale of 13-15, indicating mild or no traumatic brain injury (TBI
-
cognitive and physical ability to take part in these auditory evaluations.
-
Age 18 years or older
-
native speaker of English (since test materials are presented in English)
Control group:
-
able to commute to Portland (Oregon)VA Med Ctr.
-
no exposure to blast
-
cognitive and physical ability to take part in these auditory evaluations.
-
age 18 years or older
-
native speaker of English
Exclusion Criteria:
- hearing loss greater than 50 dB HL three-frequency pure tone average bilaterally
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Walter Reed Army Medical Center | Washington | District of Columbia | United States | 20307 |
Sponsors and Collaborators
- VA Office of Research and Development
- Walter Reed Army Medical Center
Investigators
- Principal Investigator: Marjorie R. Leek, PhD, VA Loma Linda Healthcare System, Loma Linda, CA
Study Documents (Full-Text)
None provided.More Information
Additional Information:
- Web site of the American Speech-Language Hearing Association
- web site of Defense and Veterans Brain Injury Center
Publications
- C5067-R
Study Results
Participant Flow
Recruitment Details | Active duty military who were exposed to a blast while deployed and were patients at Walter Reed Army Medical Center; only mild or no traumatic brain injury |
---|---|
Pre-assignment Detail |
Arm/Group Title | Blast-exposed | Control Group |
---|---|---|
Arm/Group Description | The study group includes soldiers who have recently been exposed to a high-explosive blast while stationed in Iraq or Afghanistan. They will be recruited at Walter Reed Army Medical Center, Washington, DC. Audiological testing: Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system. | No exposure to high-intensity blast; matched to blast-exposed group on gender, age, and hearing loss |
Period Title: Overall Study | ||
STARTED | 55 | 29 |
COMPLETED | 36 | 29 |
NOT COMPLETED | 19 | 0 |
Baseline Characteristics
Arm/Group Title | Blast-exposed | Control Group | Total |
---|---|---|---|
Arm/Group Description | The study group includes soldiers who have recently been exposed to a high-explosive blast while stationed in Iraq or Afghanistan. They will be recruited at Walter Reed Army Medical Center, Washington, DC. Audiological testing: Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system. | No exposure to high-intensity blast; matched to blast-exposed group on gender, age, and hearing loss | Total of all reporting groups |
Overall Participants | 36 | 29 | 65 |
Age (years) [Mean (Full Range) ] | |||
Mean (Full Range) [years] |
32.8
|
32.1
|
32.5
|
Sex: Female, Male (Count of Participants) | |||
Female |
4
11.1%
|
3
10.3%
|
7
10.8%
|
Male |
32
88.9%
|
26
89.7%
|
58
89.2%
|
Region of Enrollment (participants) [Number] | |||
United States |
36
100%
|
29
100%
|
65
100%
|
Outcome Measures
Title | Audiological Test Results |
---|---|
Description | Audiometric testing, with normal hearing specified as better (lower) than 25 decibels Hearing Level (dBHL), and a mild hearing loss between 25 to 50 dBHL. |
Time Frame | three years |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Blast-exposed | Control Group |
---|---|---|
Arm/Group Description | The study group includes soldiers who have recently been exposed to a high-explosive blast while stationed in Iraq or Afghanistan. They will be recruited at Walter Reed Army Medical Center, Washington, DC. Audiological testing: Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system. | No exposure to high-intensity blast; matched to blast-exposed group on gender, age, and hearing loss |
Measure Participants | 36 | 29 |
Mean (Standard Deviation) [decibels Hearing Level] |
10.8
(6.0)
|
6.6
(4.2)
|
Title | Quality of Life Questionnaire |
---|---|
Description | Self-report questionnaires regarding quality of life |
Time Frame | Three years |
Outcome Measure Data
Analysis Population Description |
---|
It was decided early during implementation of this study that the investigators would not collect self-report data on quality of life, so there are no data to report |
Arm/Group Title | Blast-exposed | Controls |
---|---|---|
Arm/Group Description | Soldiers who have been exposed to one or more blasts | Individuals who have not experienced a blast |
Measure Participants | 0 | 0 |
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Blast-exposed | Control Group | ||
Arm/Group Description | The study group includes soldiers who have recently been exposed to a high-explosive blast while stationed in Iraq or Afghanistan. They will be recruited at Walter Reed Army Medical Center, Washington, DC. Audiological testing: Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system. | No exposure to high-intensity blast; matched to blast-exposed group on gender, age, and hearing loss | ||
All Cause Mortality |
||||
Blast-exposed | Control Group | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Blast-exposed | Control Group | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/55 (0%) | 0/29 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Blast-exposed | Control Group | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/55 (0%) | 0/29 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Marjorie R. Leek |
---|---|
Organization | Portland VA Medical Center |
Phone | 503-220-8262 ext 54525 |
Marjorie.Leek@va.gov |
- C5067-R